Elisabeth von Guggenberg

Innsbruck Medical University — Austria

Medicine · Health Sciences

33h-index4.0kcitations99works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Radiopharmaceutical Chemistry and Applications(50), Neuroendocrine Tumor Research Advances(42), Lung Cancer Research Studies(37), Peptidase Inhibition and Analysis(29), Prostate Cancer Treatment and Research(16)

Publications98 total

Paving the Way for CCK2R-Targeted Peptide Receptor Radionuclide Therapy with [177Lu]Lu-DOTA-MGS5 in Patients with Small Cell Lung Cancer
Pharmaceutics·2026Open Access
Diagnostic Performance of the <sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors
Journal of Nuclear Medicine·2025· 2 cited
Peptide receptor radionuclide therapy targeting the cholecystokinin-2 receptor: Preclinical and first clinical experience in small cell lung cancer
2025Open Access
Use of 177Lu prostate-specific membrane antigen therapy in metastatic castration-resistant prostate cancer
Wiener klinische Wochenschrift·2025· 2 citedOpen Access
Safety, Biodistribution, and Radiation Dosimetry of the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Advanced Medullary Thyroid Cancer and Other Neuroendocrine Tumors
Journal of Nuclear Medicine·2025· 5 citedOpen Access
Radiopharmaceutical formulation and preliminary clinical dosimetry of [177Lu]Lu-DOTA-MGS5 for application in peptide receptor radionuclide therapy
European Journal of Nuclear Medicine and Molecular Imaging·2024· 5 citedOpen Access
Comparison of Two Chelator Scaffolds as Basis for Cholecystokinin-2 Receptor Targeting Bimodal Imaging Probes
Pharmaceuticals·2024· 5 citedOpen Access
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&amp;T radioligand therapy in metastatic castration resistant prostate cancer
European Journal of Nuclear Medicine and Molecular Imaging·2024· 8 citedOpen Access
Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer
European Journal of Nuclear Medicine and Molecular Imaging·2024· 9 citedOpen Access
Automated production of [68Ga]Ga-DOTA-exendin-4 via fractionated radionuclide generator elution on a cassette based synthesis module
Nuclear Medicine and Biology·2023· 2 cited
Improved quality control of [177Lu]Lu-PSMA I&amp;T
EJNMMI Radiopharmacy and Chemistry·2023· 8 citedOpen Access
Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R
Pharmaceutics·2023· 7 citedOpen Access
Improved Quality Control of [177Lu]Lu-PSMA I&amp;amp;T
Research Square (Research Square)·2023Open Access
Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs
Pharmaceuticals·2023· 5 citedOpen Access
Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer
Journal of Nuclear Medicine·2023· 24 citedOpen Access
Effect of Peptide Length on &lt;em&gt;in Vitro&lt;/em&gt; and &lt;em&gt;in Vivo&lt;/em&gt; Properties of &lt;sup&gt;177&lt;/sup&gt;Lu-labeled Peptide Analogs Targeting CCK2R
Preprints.org·2022· 1 citedOpen Access
Evaluation of the tumour targeting profile and characterisation of the metabolites for a novel stabilised minigastrin analogue
Nuclear Medicine and Biology·2022
Automated Synthesis of 68Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting
Molecules·2022· 10 citedOpen Access
Carcinoma primario de células pequeñas de próstata: implicación prometedora de la imagen PET con doble radiotrazador utilizando PSMA y análogos de receptores de somatostatina (SSTR)
Revista Española de Medicina Nuclear e Imagen Molecular·2021
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals
Cancers·2021· 27 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Clemens Decristoforo(34), Irene Virgolini(27), Christian Uprimny(13), Michael Gabriel(12), Dorota Kendler(10), Alexander Kroiss(9), Wolfgang Horninger(8), Bernhard Nilica(8), Roland Haubner(7), Christine Rangger(7), Josef Fritz(6), Jane Sosabowski(6), Anna Helbok(6), Daniel Putzer(6), Georg Dobrozemsky(5), Lorenza Scarpa(5), Petra Kolenc Peitl(5), Θεοδοσία Μάινα(5), Boris Warwitz(5), Maximilian Klingler(5)